NEC Baby Formula Lawsuit – Status, Verdicts & Eligibility

Families whose premature infant was fed Similac or Enfamil hospital formula and later developed necrotizing enterocolitis (NEC) are behind failure-to-warn litigation. Plaintiffs allege Abbott and Mead Johnson knew the risk and failed to warn parents and doctors. The claims are consolidated for pretrial proceedings in a federal multidistrict litigation, with parallel cases in state courts. Results split: three federal bellwether cases ended in summary judgment for Abbott, the fourth in a defense verdict for Mead Johnson. Abbott has since settled its largest known exposure. In August 2026 it resolved that exposure for about $670 million, covering the Gill verdict and 2,000 more NEC claims. Mead Johnson faces state-court trials and thousands of pending claims.

Latest Baby Formula Lawsuit Updates

August 31, 2026: Mead Johnson Wins First Federal Bellwether Trial

A federal jury in Chicago returned a unanimous defense verdict for Mead Johnson in Inman v. Mead Johnson. It was the first federal NEC bellwether trial to reach a jury [1]. Jurors found the company was not liable for a premature infant’s death after he was fed Enfamil-brand formula in the NICU. Mead Johnson said the verdict shows the science does not support NEC claims against its products.

August 20, 2026: Abbott Agrees to $670 Million Settlement

Abbott agreed to pay approximately $670 million to settle the matter. The deal resolves the $495 million Gill verdict and NEC claims for about 2,000 additional infants [2]. The settlement is partial: it does not cover Mead Johnson or resolve the federal multidistrict litigation. Three law firms represented the roughly 2,000 claimants, and Abbott called the deal a compromise of disputed claims rather than an admission of fault.

June 12, 2026: Appeals Court Reverses $60 Million Watson Verdict

The Illinois Fifth District Appellate Court reversed the $60 million verdict against Mead Johnson in Watson v. Mead Johnson, finding the trial court should have applied the learned-intermediary doctrine [3]. The panel also said the trial judge wrongly let jurors hear about Mead Johnson’s corporate wealth, and remanded the case to St. Clair County for a new trial. The original March 2024 verdict was the litigation’s first NEC jury verdict.

May 5, 2026: Missouri Court Upholds $495 Million Gill Verdict

The Missouri Court of Appeals, Eastern District, affirmed the $495 million verdict against Abbott in Gill v. Abbott without a written opinion, rejecting Abbott’s argument that the family had not proven the formula caused the child’s NEC [4]. Abbott said it would keep pursuing further appellate review. Days later, though, the company folded the judgment into the broader settlement instead.

April 10, 2026: Chicago Jury Awards $70 Million Against Abbott

A jury in Chicago found Abbott liable in four consolidated NEC cases on April 9. It then awarded $53 million in compensatory damages and $17 million in punitive damages the next day, for $70 million total [5]. An Abbott spokesperson said the company strongly disagreed with the verdict. The spokesperson argued the theory behind it risks limiting formula options doctors rely on for the most vulnerable infants.

July 26, 2024: St. Louis Jury Awards Margo Gill $495 Million

A St. Louis jury awarded Margo Gill $495 million against Abbott, finding the company’s formula contributed to her daughter’s NEC. The total included $95 million in compensatory and $400 million in punitive damages [6]. The decision was not unanimous. Nine of the 12 jurors agreed, and Abbott said there was no scientific evidence its preterm formula caused or contributed to NEC.

March 13, 2024: St. Clair County Jury Awards Jasmine Watson $60 Million

A St. Clair County, Illinois jury found Mead Johnson negligent and awarded Jasmine Watson $60 million. Jurors ruled the company failed to warn of NEC risk before her son died [7]. It was the first trial in the sprawling litigation to reach a verdict. Mead Johnson said it was disappointed and would appeal – an appeal that ultimately succeeded in June 2026.

April 8, 2022: Federal Panel Creates MDL 3026

The U.S. Judicial Panel on Multidistrict Litigation transferred the federal NEC cases against Abbott and Mead Johnson into MDL 3026 in the Northern District of Illinois. Judge Rebecca R. Pallmeyer was assigned the case. The order consolidated pretrial proceedings for efficiency. Judge Pallmeyer later selected four bellwether cases, three decided for Abbott on summary judgment. The panel’s own report shows the litigation still active as of September 2026 [8].

What Is Necrotizing Enterocolitis?

According to NICHD, necrotizing enterocolitis (NEC) is a disease of the intestinal tract in which the bowel lining becomes inflamed, dies, and can slough off. It is the most common serious gastrointestinal emergency in premature newborns [9]. NEC is central to this litigation because plaintiffs allege that Similac and Enfamil hospital formulas raised that risk in premature infants without adequate warning.

Who May Be Affected?

These claims describe infants born premature or at low birth weight. They were fed cow’s-milk-based Similac or Enfamil formula or fortifier in a hospital NICU and later developed necrotizing enterocolitis. The litigation centers on specialty formula given under a doctor’s direction in the NICU, rather than formula bought at a retail store. Circumstances vary by when the formula was given, how the NEC diagnosis was documented, and which company’s product was used. Abbott and Mead Johnson face separate claims with different trial outcomes. Cases have been filed on behalf of infants who recovered and infants who died from NEC complications. Only an individual legal review can confirm whether a specific family’s circumstances support a claim.

Reported Injuries or Damages

Plaintiffs allege that cow’s-milk-based Similac and Enfamil formulas and fortifiers contributed to necrotizing enterocolitis in premature infants. Some cases required intestinal surgery, and the most severe cases ended in death. Complaints describe the disease as a failure-to-warn injury. They allege the formula’s design itself, rather than a contaminated batch, is the cause of the child’s harm. A 2022 systematic review of NEC risk factors found that preterm infants fed formula, rather than breast or donated human milk, faced a higher risk of NEC. Even partial human-milk feeding reduced that risk, the review found [10]. A 2024 federal working-group report, later backed by U.S. health regulators, found no conclusive evidence that preterm formula itself causes NEC [11]. Regulators reviewed the evidence and found it instead supports this explanation: the absence of human milk, not exposure to formula, is associated with the higher NEC risk in preterm infants. The Similac lawsuit and Enfamil lawsuit pages cover each company’s own claims, defenses, and current case status in more detail.

Recall and Regulatory Background

Abbott recalled Similac, Alimentum and EleCare powder formula from its Sturgis, Michigan plant in February 2022. Four infants developed confirmed Cronobacter infections there, and two died. The FDA also received a separate Salmonella complaint from the same plant that investigators found unrelated to the outbreak. The agency opened an investigation and the plant closed for months [12]. That recall is separate from the NEC litigation. On September 14, 2026, Abbott agreed to pay $385 million to resolve Justice Department and state claims over the plant contamination, admitting no fault [13].

Evidence to Preserve

Families considering a necrotizing enterocolitis claim against Abbott or Mead Johnson should gather and preserve the following records and materials before meeting with a lawyer:

• NICU and hospital medical records showing which formula or fortifier brand the infant was fed
• Discharge paperwork, feeding logs, and any nursing notes documenting the infant’s NICU stay
• Records of the infant’s necrotizing enterocolitis diagnosis and treatment, including any surgery performed
• Formula product packaging, lot numbers, or supply records, if the family still has them
• Photographs of the specific product used in the hospital, if any were taken
• Correspondence with the hospital, pediatrician, or formula maker about the infant’s feeding or diagnosis

An attorney can help identify which records still exist and how to request them from a hospital or former formula supplier.

Filing Deadlines

Deadlines to file a baby formula NEC claim come from state law. They depend on where the family lives and when the infant’s NEC was diagnosed. Some states start the clock at diagnosis rather than at the formula feeding itself, and missing the window can end a claim even with strong facts. Because the timing is fact-specific, families should talk with a lawyer promptly rather than wait to confirm whether time remains to file.

Potential Compensation

Courts and settlements in the NEC litigation have addressed compensatory damages, covering medical costs and a child’s pain and suffering. In Gill v. Abbott, the jury’s award also included punitive damages of $400 million. Other trials, such as Inman v. Mead Johnson, ended with no damages awarded, showing that outcomes have differed case by case. Compensation amounts vary by case. Past results do not guarantee future outcomes. Potential compensation depends on an individual family’s diagnosis, treatment costs, and which company’s formula the medical records show was used.

Frequently Asked Questions

Has Mead Johnson Lost Any NEC Jury Trials?

No, Mead Johnson has not lost any NEC jury trials that still stand. The company says juries in two other state cases, Collins v. Mead Johnson and Whitfield v. Mead Johnson, ruled in its favor, on top of the Watson reversal.

Has Abbott Settled the Baby Formula Lawsuit?

Yes, Abbott settled part of the baby formula lawsuit in August 2026. The settlement, covering roughly 2,000 claims, was negotiated with three law firms representing the claimants. It does not cover Mead Johnson, which still faces separate cases.

What Does the Research Say About Formula and NEC?

The research on formula and NEC is mixed. A 2022 review covered 19 studies published between January 2018 and October 2021. It found formula-fed preterm infants faced a higher risk than those fed human milk, while a 2024 federal report found no conclusive evidence that formula causes NEC.

Can I Still File a Claim If My Baby Recovered from NEC?

Yes, you can still file a claim if your baby recovered from NEC. A claim rests on the surgery, hospitalization, and medical costs a family faced during treatment rather than on the outcome. The filing deadline still runs from when the diagnosis was made, rather than from full recovery.

What If My Baby Was Fed More than One Formula Brand?

If your baby was fed more than one formula brand, you can still pursue a claim. Records from each feeding help show which company’s product was used when. A lawyer can then evaluate separate claims against Abbott and Mead Johnson, rather than treating the exposure as one combined claim.

What If I No Longer Have the Formula Container as Evidence?

If you no longer have the formula container as evidence, that alone will not stop a claim. Hospital pharmacy, purchasing, or supply records often show which formula or fortifier brand and lot a NICU used, and those records can substitute for a missing container.

References

1. https://www.reckitt.com/news/mead-johnson-welcomes-defense-verdict-in-inman-case/
2. https://abbott.mediaroom.com/2026-08-20-Abbott-reaches-agreements-to-resolve-a-portion-of-litigation-involving-its-specialty-formulas-for-preterm-infants
3. https://www.isba.org/cases/illinois/appellate/2026/06/12/watsonvmeadjohnsoncompanyllc
4. https://www.newstribune.com/news/2026/may/07/court-upholds-495-million-verdict-against-abbott/
5. https://www.insurancejournal.com/news/national/2026/04/13/865692.htm
6. https://www.firstalert4.com/2024/07/27/st-louis-jury-awards-495-million-metro-east-mother-baby-formula-case/
7. https://www.insurancejournal.com/news/national/2024/03/18/765365.htm
8. https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_Actions_Pending-September-1-2026.pdf
9. https://www.nichd.nih.gov/health/topics/nec
10. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152085/
11. https://www.hhs.gov/about/news/2024/10/03/fda-cdc-nih-consensus-statement-recent-advisory-council-report-premature-infants-necrotizing-enterocolitis.html
12. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/abbott-voluntarily-expands-recall-powder-formulas-manufactured-one-plant
13. https://www.nbcnews.com/health/health-news/abbott-settle-allegations-contamination-baby-formula-rcna597750